Cipla Q3 Results FY 2026, Share Price: Leading pharmaceutical company Cipla Limited released the results for the third quarter (Q3 Quarterly Earnings) ending October-December 2025 on Thursday. Here, pharma stocks crashed after the quarterly results came out. The company told the market that Cipla Limited’s consolidated profit in the third quarter (Q3FY26) of the financial year 2025-2026 fell by 57 percent on an annual basis.
Cipla Q3 FY26 Results: Profit declined by 57% year-on-year to Rs 676 crore, shares of the pharma company fell as soon as the results came – Market.
